Equities
Basic MaterialsChemicals
  • Price (GBX)2,978.00
  • Today's Change-82.00 / -2.68%
  • Shares traded197.26k
  • 1 Year change-25.62%
  • Beta1.0041
Data delayed at least 20 minutes, as of Jul 11 2025 16:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Croda International Plc is a United Kingdom-based specialty chemicals company. The Company uses its smart science to create high performance ingredients and technologies that improve people's lives. Its sales, marketing and research activities are organized into three global market sectors: consumer care, life sciences and industrial specialties. Its consumer care sector's business units comprise beauty actives, fragrances and flavors, beauty care, and home care. It a has large actives portfolio across two ranges: Sederma Actives and Croda Botanicals. The beauty care delivers differentiated ingredients across skin, hair and solar care. The Company's life sciences sector's business units comprise agriculture (crop protection and seed enhancement) and pharma. The crop protection unit offers ingredients that improve performance and delivery of crop formulations. The pharma comprises three technology platforms: protein/small molecule delivery; adjuvant systems, and nucleic acid delivery.

  • Revenue in GBP (TTM)1.63bn
  • Net income in GBP158.50m
  • Incorporated1925
  • Employees6.03k
  • Location
    Croda International PlcCowick HallGOOLE DN14 9AAUnited KingdomGBR
  • Phone+44 140 586 0551
  • Fax+44 140 586 1767
  • Websitehttps://www.croda.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
K+S AG3.13bn0.002.44bn11.38k1,583,000.000.46015.590.78110.000010.0000120.2734.410.38914.704.99316,515.500.00214.080.00244.829.3421.930.005510.052.300.35750.074219.65-5.677.46-131.82--0.632430.26
HEXPOL AB1.59bn168.08m2.46bn4.95k15.312.2011.531.556.296.2959.5343.710.84637.366.284,133,441.008.9510.9712.4514.8721.2721.2610.5711.680.674218.840.199969.24-7.305.68-12.047.5616.3612.80
Kemira Oyj2.49bn200.12m2.47bn4.73k12.341.686.560.9911.501.5018.6410.960.8733--6.61615,921.707.415.9610.437.98--37.458.486.441.1815.910.281253.39-12.872.0925.2617.75-3.615.73
Sodas Sodyum Sanayii AS4.24m-3.65k2.55bn116.00--821.4414,662.23601.68-0.0001-0.00010.15370.11261.004.2415.451,987,972.00-0.086218.36-0.10322.4420.4026.82-0.08613.443.13--0.0041---23.2438.04-100.32--19.62--
Clariant AG3.84bn225.47m2.73bn10.47k12.041.255.600.71110.73870.738712.577.110.71524.496.91396,751.104.822.496.803.6131.0929.566.743.711.0226.670.42983.72-5.14-1.1545.24---6.28-32.51
Solvay SA4.37bn169.78m2.75bn8.67k16.302.326.110.62871.851.8547.9413.010.76416.216.35585,534.703.122.594.403.4021.8524.794.084.201.017.730.60978.01-14.84-14.50270.23---19.76-8.31
Umicore SA12.80bn-1.28bn3.02bn11.58k--1.76--0.2359-6.15-6.1561.778.061.535.3511.441,282,591.00-15.800.3984-26.830.66668.176.54-10.310.17550.7651.040.6414273.74-18.68-3.21-484.31---0.19165.92
Johnson Matthey PLC11.67bn373.00m3.15bn10.64k9.341.375.620.26962.012.0166.2913.671.869.708.661,096,768.005.953.059.905.417.706.813.201.491.017.400.426165.44-9.10-4.34245.377.90-3.386.72
Wacker Chemie AG4.93bn207.70m3.19bn16.66k14.650.75595.050.64764.854.85115.1093.990.62662.927.37343,920.202.857.023.568.7017.2421.694.569.281.48--0.28748.76-10.633.03-23.15--9.4437.97
SOL SpA1.39bn127.29m3.80bn7.29k29.884.2914.172.741.631.6317.7511.330.78953.793.40220,881.107.607.889.7410.1874.9772.789.629.861.9214.490.391922.168.2912.231.3524.528.5017.38
Croda International Plc1.63bn158.50m4.27bn6.03k26.971.8714.462.621.131.1311.6516.350.45942.524.37270,134.404.509.314.9910.6345.0846.269.8017.371.5310.060.233347.86-3.923.40-7.31-6.6810.374.10
Arkema SA8.26bn265.44m4.32bn21.15k16.080.67494.460.52264.094.09127.3597.580.65165.556.45454,605.802.225.292.696.3619.9521.183.417.061.648.380.336236.030.31531.78-15.92-7.202.8610.35
Imcd NV4.07bn239.80m5.83bn5.13k23.543.0616.321.434.864.8682.6337.481.055.626.09922,279.006.167.007.949.4022.4921.915.886.061.295.300.449344.626.4111.94-4.8020.848.3419.03
Syensqo NV5.86bn-93.08m6.32bn13.28k--1.0111.361.08-1.04-1.0465.0170.120.53633.576.71512,275.90-0.8121---0.9747--31.61---1.51--0.9552--0.2219---3.10---102.59------
Data as of Jul 11 2025. Currency figures normalised to Croda International Plc's reporting currency: UK Pound GBX

Institutional shareholders

39.31%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 31 Dec 202413.26m9.50%
Massachusetts Financial Services Co.as of 06 Mar 20257.36m5.27%
Mawer Investment Management Ltd.as of 31 Dec 20216.44m4.61%
The Vanguard Group, Inc.as of 01 Jun 20255.59m4.01%
BlackRock Investment Management (UK) Ltd.as of 01 Jun 20254.95m3.54%
BlackRock Advisors (UK) Ltd.as of 31 Dec 20244.25m3.04%
Impax Asset Management Ltd.as of 01 Jun 20253.87m2.77%
RBC Global Asset Management (UK) Ltd.as of 28 Nov 20243.65m2.62%
BlackRock Fund Advisorsas of 01 Jun 20252.77m1.99%
Royal London Asset Management Ltd.as of 01 Jun 20252.76m1.97%
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.